DOTA-MLN6907
DOTA-MLN6907 is a guanylate cyclase C (GCC) binding agent. DOTA-MLN6907 competitively binds GCC receptors in vitro with an IC50 of approximately 4.6 nM. DOTA-MLN6907, after labeling with Ga-68, can specifically bind to GCC-expressing cancer cells for PET imaging. DOTA-MLN6907 can be used for PET imaging studies of GCC-expressing tumors such as colorectal cancer and for stratified assessment of GCC expression levels.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1792977-97-9
- Formel: C85H123N21O28S7
- Molecular Weight:2111.47
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 1792977-97-9
-
Molecular Weight 2111.47
-
Formel C85H123N21O28S7
-
SMILES
O=C(O)CN1CCN(CC(O)=O)CCN(CC(O)=O)[C@@H](CC2=CC=C(NC(NCCCCCC(N[C@H](C(N[C@@H](CSSC[C@@H](C(N[C@@H](C)C(NC3)=O)=O)NC4=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC(C)C)C(N[C@@H]5CSSC[C@@H](C(N[C@@H](CC6=CC=C(C=C6)O)C(O)=O)=O)NC3=O)=O)=O)=O)=O)CSSC[C@H](C(N[C@@H](CC(N)=O)C(N7[C@@H](CCC7)C(N[C@H]4C)=O)=O)=O)NC5=O)=O)=S)C=C2)CN(CC(O)=O)CC1
-
Sequence
{(S)-p-SCN-Bn-DOTA}-Ahx-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Ala-Gly-Cys-Tyr (disulfide bridge:Cys1-Cys6, Cys2-Cys10, Cys5-Cys13)
-
Sequence Shortening
{(S)-p-SCN-Bn-DOTA}-Ahx-CCELCCNPACAGCY (disulfide bridge:Cys1-Cys6, Cys2-Cys10, Cys5-Cys13)
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)